An end to ovarian cancer within our lifetimes.
- Molly O’Connor - CEO Rivkin Center
Ovarian cancer is the deadliest gynecological cancer. Most people are diagnosed at advanced stages as there is no early detection test available for those at average risk. The five year survival rate for the disease is 47%.
The Rivkin Center is committed to supporting cutting-edge research on the prevention, early detection, and treatment of ovarian cancer to improve outcomes for those affected by the disease.